And that means as we look for the next stock split company, we can consider players that already completed such operations in ...

Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...

Alphabet's AI integration, robust cash flow, and profitable Google Cloud make it a top investment choice. See more on GOOG ...

From a trailing price-to-earnings (P/E) ratio standpoint, Alphabet hasn't been this cheap since the beginning of 2023, when ...

Isomorphic Labs, the Alphabet Inc.-owned company that uses artificial intelligence to discover drugs, has raised $600 million ...

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...

Like many tech stocks, Alphabet's (NASDAQ: GOOGL) (NASDAQ: GOOG) stock pulled back in recent months. Investors still question ...

The whole U.S. stock market is feeling the pain from the sweeping new tariffs that President Trump announced Wednesday after ...

The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...

Alphabet’s Gemini 2.5 Pro sets new AI benchmarks, powered by DeepMind and custom TPUs. Learn why GOOG stock offers long-term ...

We recently published a list of Top 10 Stocks to Watch as AI Trade Dynamics Change. In this article, we are going to take a ...